Jillian Barrack
PharmD candidate at UConn School of Pharmacy
FDA Approves Emicizumab-kxwh for Hemophilia A
FDA Approves Emicizumab-kxwh for Hemophilia A
Emicizumab-kxwh brings together factors IXa and X to restore the function of the missing activated factor VIII and the blood clotting process.

Poll